Back to search results

Robotic Telesurgery for Prostate Cancer and Benign Prostate Disease

This study is exploring a new way to perform surgery called robotic telesurgery using the Microport Medbot Robotic Platform. This means a highly skilled surgeon can operate on you from a different location using a secure internet connection. The study is looking at how safe and effective this method is for men with localized prostate cancer or benign (non-cancerous) prostate diseases that would normally be treated with robotic surgery. Researchers will be checking how well the telesurgery works in real hospitals, if there are any technical challenges like internet speed, and how it can help train new surgeons. They plan to enroll 10 participants.

Study design
This is an interventional study with an unspecified phase, planning to enroll 10 participants. It is testing a new surgical approach.
What's involved
You would undergo a robotic surgical procedure for prostate disease. The surgical procedure is expected to last approximately 90 minutes.
Compensation
Not stated in the trial record.
Follow-up
The primary and secondary outcomes will be measured from the start to the completion of the surgical procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07130708

Exploring the Potential of Robotic Telesurgery in Remote Settings

Recruiting
NAAges 18–90InterventionalDevice feasibility
AdventHealth
~10 participants
Updated 2025-08-19 on ClinicalTrials.gov
What's tested:Telesurgery utilizing Microport Medbot Robotic Platform

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Primary Outcome Measures (Endpoints)
Measured over The measured time frame for this outcome will be measured by the investigator and tech team from the start of the surgical procedure through the stop time of the surgical procedure. Approximately 90 minutes in length.
+2 more outcomes measured

Conditions

Prostate Carcinoma
Prostate Disease

Explore related trials

Benign Prostatic HyperplasiaProstate Carcinoma

Where it's being run

1 sites across 1 states
Florida1

Who to contact

Research Nurse Manager
[email protected]
407-303-4933
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18 - 90
Male or female
Eligible participants for this telesurgery study must have a clearly defined indication for robotic urologic surgery, specifically:
Localized Prostate Cancer (ICD-10: C61), appropriate for robotic radical prostatectomy.
Benign Prostate diseases appropriate for robotic simple prostatectomy (ICD-10: N40) These diagnoses are confirmed by clinical examination, imaging, and/or pathology prior to surgical planning. Patients with vague or unspecified urologic conditions will be excluded to ensure the safety and appropriateness of the surgical intervention.
Primary diagnosis of urinary system disease and prostate disorders (C61 and N40.1) scheduled to undergo treatment with robotic surgery. These patients don't have access to robotic surgery in their routine and the study will give them the opportunity to have advanced technology and the gold-standard treatment with experts in the field.
Willing to participate in the study
Mentally capable of comprehending the study protocol

Exclusion

Patients who, based on multidisciplinary evaluation (surgical, anesthetic, and medical), are deemed not suitable for robotic surgery due to high perioperative risk. This includes but is not limited to:
Uncontrolled cardiovascular, pulmonary, or metabolic disease.
Severe anesthetic risk classified as ASA Class IV or higher.
Patients enrolled in another interventional research study that may interfere with surgical safety or outcomes.
Patients unwilling or unable to comply with the perioperative and follow-up schedule.
Vulnerable populations are excluded from this study, including:
Minors (under 18 years old)
Prisoners
Cognitively impaired or decisional incapacitated individuals

What this trial measures

  • Primary Outcome Measures (Endpoints)The measured time frame for this outcome will be measured by the investigator and tech team from the start of the surgical procedure through the stop time of the surgical procedure. Approximately 90 minutes in length.

    One of the investigator's primary outcome measures is the safety and feasibility of the Microport Medbot Robotic Platform for use in Telesurgery through maintaining a stable connection. The investigator will monitor feasibility through perioperative connectivity assessment provided by the platform. Outcome of Latency- Medbot platform measures in milliseconds. This is monitored by the investigator. Measured in Milliseconds per round trip time (ms/RTT). The acceptable threshold is under 200ms. Robotic Platform Performance Logs- The robotic system itself continuously logs and reports performance metrics, including latency. Dedicated Tech team: Oversees and monitors connection status throughout procedure.

  • Secondary EndpointsThis will be measured by the investigator from the start of the surgical procedure through the completion of the surgical procedure.

    Investigators assessment of and response to perioperative complications (complications observed will be classified using the Clavien-Dindo Classification with Grades I thru V).

  • Safety and Feasibility: Maintenance of stable connectionThe measured time frame for this outcome will be measured by the investigator and tech team from the start of the surgical procedure through the stop time of the surgical procedure. Approximately 90 minutes in length.

    One of the investigator's primary outcome measures is the safety and feasibility of the Microport Medbot Robotic Platform for use in Telesurgery through maintaining a stable connection. The investigator will monitor feasibility through perioperative connectivity Outcome: Bandwidth and Network Stability- The surgical team monitors bandwidth to ensure a consistent, high-speed internet connection. Bandwidth measured in megabits per second (Mbps). The goal of 100Mbps is recommended. Measurement is made through tracking on data transmission rates reported by the robotic system itself which continuously logs and reports data in real time. Dedicated Tech Team: Oversees and monitors connection status throughout the procedure.